Document is current
Any future updates will be listed below
-
Authors
Can, Ismail
Siegler, Elizabeth L.
Sirpilla, Olivia L.
Manriquez-Roman, Claudia
Yun, Kun
Stewart, Carli M.
Feigin, Jennifer M.
Rodriguez, Makena L.
Gutierrez-Ruiz, Omar L.
Ogbodo, Ekene J.
Huynh, Truc N.
Kimball, Brooke L.
Mai, Long K.
Hefazi, Mehrdad
Fonkoua, Lionel Kankeu
Xia, Hong
Hamaidi, Imene
Alkan, Berke
Sezer, Fatih
Ekiz, H. Atakan
Sakemura, R. Leo
Kenderian, Saad S.
-
Funding
Funding for this research was provided by:
Regenerative Medicine Minnesota (072523 TR 004)
Mayo Clinic Division of Hematology
Eagles 5th District Cancer Telethon Funds for Cancer Research
Predolin Foundation
Mayo Clinic Center for Individualized Medicine
Mayo Clinic Comprehensive Cancer Center
Mayo Clinic Center for Regenerative Biotherapeutics
National Institutes of Health (R37CA266344-01)
Department of Defense grant (CA201127)
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 28 May 2025
First Online: 10 June 2025
Declarations
:
: The use of recombinant DNA in the laboratory was approved by the Mayo Clinic Institutional Biosafety Committee (IBC), IBC number HIP00000252.43. Animal studies were performed according to the Institutional Animal Care and Use Committee (IACUC) at the Mayo Clinic animal facilities (IACUC # A00001767-16-R22).
: SSK is an inventor on patents in the field of CAR immunotherapy that are licensed to Novartis (through an agreement between Mayo Clinic, University of Pennsylvania, and Novartis), and MustangBio (through Mayo Clinic). RLS, and SSK are inventors on patents in the field of CAR immunotherapy that are licensed to Humanigen/Taran (through Mayo Clinic). IC, ELS, OLS, CMR, KY, CMS, JMF, OGR, TNH, BLK, LKM, MH, HX, RLS and SSK are inventors on patents that are licensed to Immix Biopharma. SSK receives research funding from Kite, Gilead, Juno, BMS, Novartis, Humanigen, MorphoSys, Tolero, Sunesis/Viracta, LifEngine Animal Health Laboratories Inc, and Lentigen. SSK has participated in advisory meetings with Kite/Gilead, Humanigen, Juno/BMS, Capstan Bio, and Novartis. SSK has served on the data safety and monitoring board with Humanigen, and Carisma. SSK has severed a consultant for Torque, Calibr, Novartis, Kite, Capstan Bio, Luminary, Carisma, and Humanigen.
